CARYSIL
|
CARYSIL Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 34.51 | 22.44 | 21.60 | 19.58 | 24.26 |
| CEPS(Rs) | 48.69 | 35.29 | 33.88 | 29.58 | 31.08 |
| DPS(Rs) | 3.00 | 2.40 | 2.00 | 2.00 | 2.40 |
| Book NAV/Share(Rs) | 213.86 | 185.11 | 131.45 | 112.35 | 93.65 |
| Tax Rate(%) | 23.81 | 26.78 | 27.75 | 22.42 | 24.19 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 19.47 | 17.15 | 19.13 | 18.44 | 21.63 |
| EBIT Margin(%) | 16.49 | 13.96 | 15.17 | 14.27 | 20.04 |
| Pre Tax Margin(%) | 14.06 | 10.77 | 11.81 | 11.47 | 17.79 |
| PAT Margin (%) | 10.71 | 7.89 | 8.54 | 8.90 | 13.49 |
| Cash Profit Margin (%) | 14.99 | 12.29 | 13.28 | 13.33 | 17.15 |
| Performance Ratios | |||||
| ROA(%) | 10.02 | 7.23 | 7.50 | 8.35 | 13.82 |
| ROE(%) | 17.45 | 14.65 | 17.87 | 19.18 | 29.57 |
| ROCE(%) | 18.25 | 15.77 | 17.63 | 18.52 | 28.38 |
| Asset Turnover(x) | 0.94 | 0.92 | 0.88 | 0.94 | 1.02 |
| Sales/Fixed Asset(x) | 1.35 | 1.36 | 1.34 | 1.57 | 1.79 |
| Working Capital/Sales(x) | 5.79 | 4.62 | 11.59 | 13.92 | 7.45 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.74 | 0.74 | 0.75 | 0.64 | 0.56 |
| Receivable days | 60.59 | 63.51 | 64.28 | 62.51 | 69.17 |
| Inventory Days | 94.86 | 88.24 | 81.07 | 72.15 | 59.88 |
| Payable days | 85.76 | 88.56 | 106.11 | 104.51 | 131.01 |
| Valuation Parameters | |||||
| PER(x) | 21.84 | 27.84 | 45.44 | 27.75 | 34.25 |
| PCE(x) | 15.48 | 17.71 | 28.97 | 18.37 | 26.73 |
| Price/Book(x) | 3.52 | 3.38 | 7.47 | 4.84 | 8.87 |
| Yield(%) | 0.40 | 0.38 | 0.20 | 0.37 | 0.29 |
| EV/Net Sales(x) | 2.55 | 2.42 | 4.26 | 2.80 | 4.84 |
| EV/Core EBITDA(x) | 12.20 | 13.17 | 21.42 | 14.97 | 20.43 |
| EV/EBIT(x) | 15.46 | 17.32 | 28.12 | 19.63 | 24.17 |
| EV/CE(x) | 2.68 | 2.49 | 4.47 | 3.17 | 4.24 |
| M Cap / Sales | 2.32 | 2.18 | 3.85 | 2.45 | 4.58 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 13.29 | 19.28 | 15.13 | 22.73 | 56.24 |
| Core EBITDA Growth(%) | 28.92 | 9.99 | 22.54 | -3.16 | 53.18 |
| EBIT Growth(%) | 33.83 | 9.79 | 22.37 | -12.64 | 55.87 |
| PAT Growth(%) | 53.87 | 10.21 | 10.47 | -19.04 | 65.97 |
| EPS Growth(%) | 53.78 | 3.90 | 10.32 | -19.29 | 65.53 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.44 | 0.50 | 0.85 | 0.73 | 0.55 |
| Current Ratio(x) | 1.44 | 1.59 | 1.17 | 1.14 | 1.27 |
| Quick Ratio(x) | 0.72 | 0.85 | 0.68 | 0.72 | 0.84 |
| Interest Cover(x) | 6.78 | 4.38 | 4.52 | 5.09 | 8.88 |
| Total Debt/Mcap(x) | 0.13 | 0.15 | 0.11 | 0.15 | 0.06 |
Compare Financial Ratios of peers of CARYSIL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CARYSIL | ₹3,238.9 Cr | 0.8% | -6.3% | 33.9% | Stock Analytics | |
| HINDUSTAN UNILEVER | ₹463,809.0 Cr | -1.1% | -5.3% | -26.1% | Stock Analytics | |
| GODREJ CONSUMER PRODUCTS | ₹90,050.8 Cr | -2.6% | -18.6% | -30.4% | Stock Analytics | |
| DABUR INDIA | ₹67,454.7 Cr | -0.8% | -8.2% | -27.4% | Stock Analytics | |
| COLGATEPALMOLIVE (INDIA) | ₹49,936.6 Cr | -1% | -9.6% | -21.7% | Stock Analytics | |
| PROCTER & GAMBLE HYGIENE AND HEALTH CARE | ₹24,903.6 Cr | -4% | -9.6% | -42% | Stock Analytics | |
CARYSIL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CARYSIL | 0.8% |
-6.3% |
33.9% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses